Literature DB >> 30742097

Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma.

Irene Vázquez-Domínguez1,2, Laura González-Sánchez1,2,3, Pilar López-Nieva1,2,3, Pablo Fernández-Navarro4,5, María Villa-Morales1,2,3, María Á Cobos-Fernández1,2, Isabel Sastre1, Mario F Fraga6, Agustín F Fernández7, Marcos Malumbres8, María Salazar-Roa8, Osvaldo Graña-Castro9, Javier Santos1,2,3, Pilar Llamas2, José L López-Lorenzo2, José Fernández-Piqueras10,11,12.   

Abstract

FBXW7 is a driver gene in T-cell lymphoblastic neoplasia acting through proteasome degradation of key proto-oncogenes. FBXW7 encodes three isoforms, α, β and γ, which differ only in the N-terminus. In this work, massive sequencing revealed significant downregulation of FBXW7 in a panel of primary T-cell lymphoblastic lymphomas characterised by the absence of mutations in its sequence. We observed that decreased expression mainly affected the FBXW7β isoform and to a lesser extent FBXW7α and may be attributed to the combined effect of epigenetic changes, alteration of upstream factors and upregulation of miRNAs. Transient transfections with miRNA mimics in selected cell lines resulted in a significant decrease of total FBXW7 expression and its different isoforms separately, with the consequent increment of critical substrates and the stimulation of cell proliferation. Transient inhibition of endogenous miRNAs in a T-cell lymphoblastic-derived cell line (SUP-T1) was capable of reversing these proliferative effects. Finally, we show how FBXW7 isoforms display different roles within the cell. Simultaneous downregulation of the α and γ isoforms modulates the amount of CCNE1, whilst the β-isoform alone was found to have a prominent role in modulating the amount of c-MYC. Our data also revealed that downregulation of all isoforms is a sine qua non condition to induce a proliferative pattern in our cell model system. Taking these data into account, potential new treatments to reverse downregulation of all or a specific FBXW7 isoform may be an effective strategy to counteract the proliferative capacity of these tumour cells.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30742097     DOI: 10.1038/s41388-019-0746-1

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  63 in total

1.  Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL.

Authors:  Sahoko Matsuoka; Yuichi Oike; Ichiro Onoyama; Atsushi Iwama; Fumio Arai; Keiyo Takubo; Yoichi Mashimo; Hideyuki Oguro; Eriko Nitta; Keisuke Ito; Kana Miyamoto; Hiroki Yoshiwara; Kentaro Hosokawa; Yuka Nakamura; Yumiko Gomei; Hiroko Iwasaki; Yasuhide Hayashi; Yumi Matsuzaki; Keiko Nakayama; Yasuo Ikeda; Akira Hata; Shigeru Chiba; Keiichi I Nakayama; Toshio Suda
Journal:  Genes Dev       Date:  2008-03-26       Impact factor: 11.361

2.  The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.

Authors:  Alena Malyukova; Takeaki Dohda; Natalie von der Lehr; Shahab Akhoondi; Shahab Akhondi; Martin Corcoran; Mats Heyman; Charles Spruck; Dan Grandér; Urban Lendahl; Olle Sangfelt
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

Review 3.  Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases?

Authors:  Birgit Burkhardt
Journal:  Br J Haematol       Date:  2009-11-24       Impact factor: 6.998

4.  Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence.

Authors:  Bettina R Bonn; Marius Rohde; Martin Zimmermann; David Krieger; Ilske Oschlies; Felix Niggli; Grazyna Wrobel; Andishe Attarbaschi; Gabriele Escherich; Wolfram Klapper; Alfred Reiter; Birgit Burkhardt
Journal:  Blood       Date:  2013-02-08       Impact factor: 22.113

5.  Promoter hypermethylation is not the major mechanism for inactivation of the FBXW7 beta-form in human gliomas.

Authors:  Zhaodi Gu; Kenichi Inomata; Hidetoshi Mitsui; Akira Horii
Journal:  Genes Genet Syst       Date:  2008-08       Impact factor: 1.517

Review 6.  F-box proteins: the key to protein degradation.

Authors:  Margaret S Ho; Pei-I Tsai; Cheng-Ting Chien
Journal:  J Biomed Sci       Date:  2006-03       Impact factor: 8.410

Review 7.  Regulating Fbw7 on the road to cancer.

Authors:  Wenshan Xu; Lyudmyla Taranets; Nikita Popov
Journal:  Semin Cancer Biol       Date:  2015-10-13       Impact factor: 15.707

8.  MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma.

Authors:  Xufu Wei; Chengyong Tang; Xiuxian Lu; Rui Liu; Mi Zhou; Diao He; Daofeng Zheng; Chao Sun; Zhongjun Wu
Journal:  Oncotarget       Date:  2015-07-30

9.  NF-κB1 inhibits c-Myc protein degradation through suppression of FBW7 expression.

Authors:  Haishan Huang; Li Ma; Jingxia Li; Yonghui Yu; Dongyun Zhang; Jinlong Wei; Honglei Jin; Derek Xu; Jimin Gao; Chuanshu Huang
Journal:  Oncotarget       Date:  2014-01-30

10.  The prognostic value of decreased miR-101 in various cancers: a meta-analysis of 12 studies.

Authors:  Jianpei Hu; Chunyu Wu; Xueying Zhao; Chaodong Liu
Journal:  Onco Targets Ther       Date:  2017-07-24       Impact factor: 4.147

View more
  1 in total

1.  The E3 ubiquitin ligase, FBXW5, promotes the migration and invasion of gastric cancer through the dysregulation of the Hippo pathway.

Authors:  Yangyang Yao; Zhen Liu; Shanshan Huang; Chunye Huang; Yuan Cao; Li Li; Hui Guo; Fenfen Liu; Shipeng Huang; Quan Liao; Xin He; Jun Chen; Junhe Li; Xiaojun Xiang; Jianping Xiong; Jun Deng
Journal:  Cell Death Discov       Date:  2022-02-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.